Raffi Asadorian

2018 - AcelRx Pharmaceuticals

In 2018, Raffi Asadorian earned a total compensation of $907.2K as Chief Financial Officer at AcelRx Pharmaceuticals, a 50% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$160,000
Option Awards$336,235
Salary$400,000
Other$11,000
Total$907,235

Asadorian received $400K in salary, accounting for 44% of the total pay in 2018.

Asadorian also received $160K in non-equity incentive plan, $336.2K in option awards and $11K in other compensation.

Rankings

In 2018, Raffi Asadorian's compensation ranked 9,664th out of 14,244 executives tracked by ExecPay. In other words, Asadorian earned more than 32.2% of executives.

ClassificationRankingPercentile
All
9,664
out of 14,244
32nd
Division
Manufacturing
3,891
out of 5,765
33rd
Major group
Chemicals And Allied Products
1,466
out of 2,128
31st
Industry group
Drugs
1,236
out of 1,817
32nd
Industry
Pharmaceutical Preparations
951
out of 1,391
32nd

Pay ratio

Raffi Asadorian's Pay$907,235
Median Employee's Pay$328,891
Pay Ratio

3

to 1

In 2018, the annual total compensation of Raffi Asadorian was $907,235.

The annual total compensation of the median employee at AcelRx Pharmaceuticals was $328,891.

The ratio of Raffi Asadorian's pay to the pay of median employee was therefore 3 to one.

Source: SEC filing on May 14, 2019.

Asadorian's colleagues

We found four more compensation records of executives who worked with Raffi Asadorian at AcelRx Pharmaceuticals in 2018.

2018

Vincent Angotti

AcelRx Pharmaceuticals

Chief Executive Officer

2018

Pamela Palmer

AcelRx Pharmaceuticals

Chief Medical Officer

2018

Badri Dasu

AcelRx Pharmaceuticals

Chief Engineering Officer

2018

Lawrence Hamel

AcelRx Pharmaceuticals

Chief Development Officer

News

You may also like